GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Foresee Pharmaceuticals Co Ltd (ROCO:6576) » Definitions » 3-Year FCF Growth Rate

Foresee Pharmaceuticals Co (ROCO:6576) 3-Year FCF Growth Rate : -73.30% (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Foresee Pharmaceuticals Co 3-Year FCF Growth Rate?

Foresee Pharmaceuticals Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was NT$-1.90.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -73.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 11 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Foresee Pharmaceuticals Co was 34.50% per year. The lowest was -73.30% per year. And the median was -0.90% per year.


Competitive Comparison of Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate falls into.


;
;

Foresee Pharmaceuticals Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Foresee Pharmaceuticals Co  (ROCO:6576) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Foresee Pharmaceuticals Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Foresee Pharmaceuticals Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Foresee Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilized injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.

Foresee Pharmaceuticals Co Headlines

No Headlines